Registrational Phase 3 study for advanced melanoma immunotherapy delivered with PharmaJet's IM Needle-free System planned for ...

Intas has signed an exclusive agreement with SII-backed IntegriMedical to deploy needle-free injection systems across IVF ...

Intas Pharmaceuticals, a leading multinational pharmaceutical company, has entered into an exclusive agreement with ...

Intas partners with IntegriMedical for needle-free injection system in IVF & gynecology. Aims to improve patient experience and reduce anxiety.

Intas collaborates with IntegriMedical to launch India’s first needle-free injection system for IVF and gynaecology: Our ...

Intas Pharmaceuticals on Monday said it has tied up with IntegriMedical to introduce a needle free injection system for use in IVF and gynecology treatments. As part of the agreement, Intas has become ...

Intas Pharmaceuticals has partnered with IntegriMedical to launch India's first needle-free injection system for IVF and gynecology treatments. This initiative aims to transform patient care by ...

Indian pharma eyes promising prospects with needle-free drug delivery transforming patient safety & comfort: Nandita Vijayasimha, Bengaluru Tuesday, January 6, 2026, 09:00 Hrs [IS ...

Diorasis Therapeutics, a Boston-based biotechnology company developing durable gene therapies for glaucoma and other ...

Enthorin Therapeutics, LLC, a biotechnology company focused on circuit-modulating treatments for neurological and neurodevelopmental disorders, announced that its licensing partner for MRM-3379 ...

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...

Why U.S. patients choose Istanbul over California and an analysis of top clinics (Hermest, ASMED), AISP technology, and JCI ...